Unbiased AI-powered news
Talks between Brown-Forman and Pernod Ricard on a $15 billion combination fell apart after the families controlling the companies failed to agree on stakes in a merged entity. The Brown family sought a larger ownership share than the Ricard family despite Pernod Ricard billing the offer as a merger of equals. Brown-Forman remains in discussions with Sazerac.
forbes.comBrown-Forman and Pernod Ricard’s $15 billion deal talks fell apart not over price but over control. The two families behind the liquor giants could not agree on how much of the combined company each would control, Semafor reported. The Brown family wields about 80% of Brown-Forman’s voting power.
The Ricard heirs control about 21% of Pernod Ricard, whose controlling shareholder is the Ricard family. Brown-Forman is the slightly smaller of the two companies. Yet the Brown family wanted an ownership stake in the combined company that would have been larger than the Ricard family’s stake, Semafor reported.
Pernod Ricard’s offer was billed as a merger of equals. The structure gave rise to thorny issues that the two sides could not resolve. Brown-Forman and Pernod Ricard were not far apart on price, according to people close to both companies.
The talks collapsed over family control rather than valuation. The Ricard family remains open to reengaging with Brown-Forman if the Brown family is willing to open discussions on control, one of the people briefed on the conversations told Semafor.
Heirs of the Kentucky whiskey empire, the smaller of the two companies, wanted more control over the combined company, people familiar with the matter said.
Brown-Forman is still in discussions with Sazerac. Sazerac is controlled by the New Orleans-based Goldring family. Representatives for Brown-Forman and Pernod Ricard declined to comment.
Single source — no framing comparison available.
screenrant.comKent Carpenter, 73, was killed by three masked men who forced entry into his house in Sibulan on Sunday night. The attackers stole a laptop, cash and a backpack. His Filipina companion was injured and received treatment.
Retired pilot Chesley Sullenberger said on July 14, 2026, that he has early-stage Alzheimer’s disease. He described initial symptoms and expressed resolve to face the condition with his family.
Japan TimesThe University of Oxford has started an early-stage clinical trial of a vaccine targeting the Bundibugyo strain of Ebola. The trial will enroll 50 healthy adults to test safety and immune response.